Vitae Pharmaceuticals, Inc. | TalkMarkets

Latest Posts

6 Best Performing Drug Stocks Of September 2016

Article By: Arpita Dutt

Monday, October 3, 2016 12:05 PM EDT

Quite a few pharma and biotech stocks had an impressive run in the month of September thanks to acquisition announcements, positive data readouts, and FDA approvals. Here is a look at 6 of the best-performing drug stocks of September.

In this article: ARRY, CLVS, SRPT, VTAE, AERI, TBRA

Read

5 Top Performing Stocks Of The Best ETF Of Q3

Article By: Sweta Killa

Friday, September 30, 2016 10:47 AM EDT

After a huge sell-off at the start of the year, the biotech sector has made a strong comeback with BioShares Biotechnology Clinical Trials Fund topping the list of the best performing ETFs of 3Q16.

In this article: ARRY, CLVS, PBYI, SRPT, VTAE, BBC

Read

Biopharma Stocks Show Resilience In Yo-Yo Week

Article By: Rod Raynovich

Friday, September 16, 2016 1:44 AM EDT

Traders “whipsawed” biotech stocks but still the IBB managed to hold onto short-term gains of 10 points over the intermediate support of $280.

In this article: AGN, BMY, ACRX, IBB, AMGN, GILD, XBI, VTAE, BLUE, AERI

Read

The 3 Best Developmental Stage Biotech Stocks Surging Now

Article By: Zacks Investment Research

Wednesday, May 25, 2016 10:54 PM EDT

Every week, there are small, under-the-radar companies that see their share prices surge immensely. Not all of these companies are worth being bullish on, but the Zacks Rank helps to find companies that might be worth taking a chance on.

In this article: GLYC, VTAE, DMTX

Read